These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3884010)

  • 21. Studies on cathepsins of rat liver lysosomes. III. Hydrolysis of peptides, and inactivation of angiotensin and bradykinin by cathepsin A.
    Matsuda K
    J Biochem; 1976 Oct; 80(4):659-69. PubMed ID: 13061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of enzymes from inflammatory cells on airway submucosal gland secretion.
    Nadel JA
    Respiration; 1991; 58 Suppl 1():3-5. PubMed ID: 1925074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The granulocyte-angiotensin system. Angiotensin I-converting activity of cathepsin G.
    Klickstein LB; Kaempfer CE; Wintroub BU
    J Biol Chem; 1982 Dec; 257(24):15042-6. PubMed ID: 6294088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines.
    Zhao W; Oskeritzian CA; Pozez AL; Schwartz LB
    J Immunol; 2005 Aug; 175(4):2635-42. PubMed ID: 16081839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I.
    Schechter NM; Fräki JE; Geesin JC; Lazarus GS
    J Biol Chem; 1983 Mar; 258(5):2973-8. PubMed ID: 6338010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New developments in the genetics and activation of mast cell proteases.
    Caughey GH
    Mol Immunol; 2002 Sep; 38(16-18):1353-7. PubMed ID: 12217407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
    Hecquet C; Tan F; Marcic BM; Erdös EG
    Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.
    Frank BT; Rossall JC; Caughey GH; Fang KC
    J Immunol; 2001 Feb; 166(4):2783-92. PubMed ID: 11160345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases.
    Schoenberger OL; Sprows JL; Schechter NM; Cooperman BS; Rubin H
    FEBS Lett; 1989 Dec; 259(1):165-7. PubMed ID: 2599103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catabolism of intact type VI collagen microfibrils: susceptibility to degradation by serine proteinases.
    Kielty CM; Lees M; Shuttleworth CA; Woolley D
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1230-6. PubMed ID: 8466500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
    He S; Walls AF
    Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phe5(4-nitro)-bradykinin: a chromogenic substrate for assay and kinetics of the metalloendopeptidase meprin.
    Wolz RL; Bond JS
    Anal Biochem; 1990 Dec; 191(2):314-20. PubMed ID: 1964766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro inactivation and formation of plasma kinins by spleen cathepsins.
    Greenbaum LM; Yamafuji K
    Br J Pharmacol Chemother; 1966 May; 27(1):230-8. PubMed ID: 5961467
    [No Abstract]   [Full Text] [Related]  

  • 36. Kallidin and bradykinin metabolism by isolated cerebral microvessels.
    Bausback HH; Ward PE
    Biochem Pharmacol; 1988 Aug; 37(15):2973-8. PubMed ID: 3395372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic degradation of endothelin-1 by activated human polymorphonuclear neutrophils.
    Fagny C; Michel A; Nortier J; Deschodt-Lanckman M
    Regul Pept; 1992 Nov; 42(1-2):27-37. PubMed ID: 1475405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease actions on airway secretions. Relevance to cystic fibrosis.
    Nadel JA
    Ann N Y Acad Sci; 1991; 624():286-96. PubMed ID: 2064229
    [No Abstract]   [Full Text] [Related]  

  • 39. Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
    Reimer JM; Enoksson M; Samollow PB; Hellman L
    Mol Immunol; 2008 Apr; 45(7):2116-25. PubMed ID: 18022236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cloning and characterization of mouse mast cell chymases.
    Chu W; Johnson DA; Musich PR
    Biochim Biophys Acta; 1992 May; 1121(1-2):83-7. PubMed ID: 1376147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.